Peregrine Capital Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Peregrine Capital Management’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-119,983	Closed	-$11.2M	–	350
2021 Q4	$11.2M	Buy	119,983 +3,375	+3%	+$222K	0.22%	173
2021 Q3	$6.94M	Sell	116,608 -22,922	-16%	-$1.35M	0.14%	237
2021 Q2	$9.52M	Sell	139,530 -7,371	-5%	-$480K	0.17%	237
2021 Q1	$10.2M	Sell	146,901 -20,453	-12%	-$1.57M	0.19%	230
2020 Q4	$12.9M	Buy	+167,354	New	+$12.5M	0.24%	197

Peregrine Capital Management's ARNA Position: Q1 2022 in Review

Peregrine Capital Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 119,983 shares — an estimated $11.2M sold.

Peregrine Capital Management first reported a position in ARNA in Q4 2020 and held it in 5 quarters. The position peaked at $12.9M in Q4 2020. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Peregrine Capital Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Peregrine Capital Management sold 119,983 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $11.2M.
Peregrine Capital Management first reported a position in Arena Pharmaceuticals Inc in Q4 2020 and held it in 5 quarters.
Peregrine Capital Management's Arena Pharmaceuticals Inc position peaked at $12.9M in Q4 2020.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Peregrine Capital Management's 13F filing for Q1 2022, filed 27 Apr 2022.